Allworth Financial’s Cardiff Oncology CRDF Stock Holding History

Allworth Financial’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$926	Buy	712 +692	+3,460%	+$1.1K	﹤0.01%	4730
2026 Q1	$33	Buy	+20	New	+$41	﹤0.01%	5103
2025 Q3	–	Sell	-100	Closed	-$315	–	4937
2025 Q2	$315	Hold	100	–	–	﹤0.01%	4238
2025 Q1	$290	Hold	100	–	–	﹤0.01%	3802
2024 Q4	$354	Hold	100	–	–	﹤0.01%	3677
2024 Q3	$267	Hold	100	–	–	﹤0.01%	3545
2024 Q2	$225	Hold	100	–	–	﹤0.01%	3535
2024 Q1	$534	Hold	100	–	–	﹤0.01%	3268
2023 Q4	$148	Hold	100	–	–	﹤0.01%	3316
2023 Q3	$139	Hold	100	–	–	﹤0.01%	3279
2023 Q2	$147	Hold	100	–	–	﹤0.01%	3141
2023 Q1	$165	Hold	100	–	–	﹤0.01%	3045
2022 Q4	$140	Hold	100	–	–	﹤0.01%	2874
2022 Q3	$0	Hold	100	–	–	﹤0.01%	2729
2022 Q2	$0	Hold	100	–	–	﹤0.01%	2463
2022 Q1	$0	Hold	100	–	–	﹤0.01%	2157
2021 Q4	$1K	Hold	100	–	–	﹤0.01%	1802
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	1738
2021 Q2	$1K	Sell	100 -858	-90%	-$7.28K	﹤0.01%	1449
2021 Q1	$9K	Buy	+958	New	+$11.6K	﹤0.01%	1009

Other funds holding CRDF

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Allworth Financial's CRDF Position: Q2 2026 in Review

Allworth Financial increased its Cardiff Oncology (CRDF) stake by 3,460% in Q2 2026, buying an estimated $1.1K and bringing the position to 712 shares worth $926. The position accounts for ﹤0.01% of the portfolio, ranked #4730.

Allworth Financial first reported a position in CRDF in Q1 2021 and has held it in 20 quarters since. The position peaked at $9K in Q1 2021. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

Allworth Financial held 712 shares of Cardiff Oncology worth $926 as of Q2 2026.
Allworth Financial bought 692 Cardiff Oncology shares in Q2 2026, an estimated $1.1K.
Cardiff Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4730 holding.
Allworth Financial first reported a position in Cardiff Oncology in Q1 2021 and has held it in 20 quarters since.
Allworth Financial's Cardiff Oncology position peaked at $9K in Q1 2021.
105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.